A. Andoh et al., Epithelial expression of caveolin-2, but not caveolin-1, is enhanced in the inflamed mucosa of patients with ulcerative colitis, INFLAMM B D, 7(3), 2001, pp. 210-214
Caveolae are vesicular invaginations of the plasma membrane that act as a s
caffold of the assembly of many classes of signaling molecules, Caveolins a
re the principal structural component of caveolae membranes, and three dist
inct forms of caveolins have been identified: caveolin-1, caveolin-2, and c
aveolin-3. In this study, we evaluated the changes in the caveolin-1 and ca
veolin-2 expression in the inflamed mucosa of patients with IBD. Tissue sam
ples were obtained endoscopically from patients with ulcerative colitis (UC
) (n = 18), Crohn's disease (n = 10) and ischemic colitis (n = 8). Normal c
olorectal tissues were also obtained (n = 15). The caveolin expression was
evaluated by standard immunohistochemical procedure. In normal colonic muco
sa, caveolin-1 expression was detected in the smooth-muscle cells of the mu
scularis mucosae and the endothelial cells, but caveolin-2 expression was n
ot detected. In the inflamed mucosa of patients with active UC, caveolin-2
expression was clearly detectable as small scattered foci on the luminal su
rfaces of epithelial cells, but caveolin-1 expression was similar to that i
n normal mucosa. Caveolin-2 expression increased in accordance with the dis
ease activity of UC. This enhanced caveolin-2 expression was not detected i
n active Crohn's disease or ischemic colitis. In conclusion, we demonstrate
d that the epithelial expression of caveolin-2 is markedly enhanced in the
inflamed mucosa of patients with UC. It is likely that the enhanced caveoli
n-2 expression in patients with UC was associated with the altered signal t
ransductions in the intestinal epithelial cells. Furthermore, our results s
uggest that there are differences in the phenotypic features of epithelial
cells between UC and Crohn's disease.